Indivior pulls full year guidance as Dr Reddy's sneak launch hits sales and Sublocade disappoints
Addiction treatment specialist Indivior (INDV) has pulled its earnings guidance for the year to 31 December 2018 following a sneaky launch from rival Dr Reddy's Laboratories.Investors may not receive any full year guidance...
11 July 2018